Total Payments
$12,347
2024 Payments
$529.62
Companies
23
Transactions
171
Medicare Patients
10,503
Medicare Billing
$6.3M
Payment Breakdown by Category
Food & Beverage$8,380 (67.9%)
Gifts$3,924 (31.8%)
Other$43.36 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,380 | 169 | 67.9% |
| Gift | $3,924 | 1 | 31.8% |
| Entertainment | $43.36 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Carl Zeiss Meditec, Inc. | $3,924 | 1 | $0 (2019) |
| Allergan, Inc. | $2,519 | 44 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $1,279 | 24 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $924.68 | 7 | $0 (2023) |
| Genentech USA, Inc. | $857.26 | 41 | $0 (2024) |
| ABBVIE INC. | $501.69 | 7 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $474.61 | 11 | $0 (2024) |
| Alimera Sciences, Inc. | $320.79 | 13 | $0 (2023) |
| Alcon Laboratories Inc | $253.95 | 2 | $0 (2018) |
| Horizon Therapeutics plc | $229.55 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $529.62 | 16 | Apellis Pharmaceuticals, Inc. ($239.43) |
| 2023 | $1,232 | 31 | Regeneron Pharmaceuticals, Inc. ($409.87) |
| 2022 | $1,348 | 23 | Genentech USA, Inc. ($315.26) |
| 2021 | $568.75 | 14 | Allergan, Inc. ($161.60) |
| 2020 | $602.39 | 10 | Allergan, Inc. ($176.59) |
| 2019 | $5,540 | 31 | Carl Zeiss Meditec, Inc. ($3,924) |
| 2018 | $1,230 | 20 | Allergan Inc. ($705.37) |
| 2017 | $1,297 | 26 | Allergan Inc. ($777.73) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: EYE CARE | ||||||
| 11/22/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Ophthalmology | ||||||
| 11/15/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Ophthalmology | ||||||
| 09/23/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Ophthalmology | ||||||
| 07/16/2024 | Oculus Surgical Inc. | — | Food and Beverage | Cash or cash equivalent | $27.38 | General |
| 07/01/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $113.43 | General |
| Category: Ophthalmology | ||||||
| 06/17/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Ophthalmology | ||||||
| 06/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: Ophthalmology | ||||||
| 05/28/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Ophthalmology | ||||||
| 04/30/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Ophthalmology | ||||||
| 04/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: EYE CARE | ||||||
| 04/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/26/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Ophthalmology | ||||||
| 03/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $2.90 | General |
| Category: Ophthalmology | ||||||
| 01/31/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: Ophthalmology | ||||||
| 12/19/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/19/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $3.86 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/01/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/17/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $149.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/26/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/01/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $20.11 | General |
| 08/26/2023 | Oculus Surgical Inc. | — | Food and Beverage | Cash or cash equivalent | $110.38 | General |
| 08/26/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $106.89 | General |
| Category: EYE CARE | ||||||
| 07/29/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: Immunology and Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,580 | 53,630 | $5.9M | $2.1M |
| 2022 | 15 | 2,618 | 9,727 | $4.4M | $1.5M |
| 2021 | 13 | 2,513 | 7,466 | $4.2M | $1.5M |
| 2020 | 12 | 2,792 | 6,368 | $3.6M | $1.2M |
Total Patients
10,503
Total Services
77,191
Medicare Billing
$6.3M
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 95 | 46,260 | $3.5M | $1.3M | 38.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 34 | 304 | $608,000 | $208,012 | 34.2% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 18 | 1,110 | $328,950 | $132,148 | 40.2% |
| J3490 | Unclassified drugs | Office | 2023 | 13 | 46 | $351,000 | $104,340 | 29.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 149 | 864 | $473,800 | $85,630 | 18.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 349 | 1,064 | $100,949 | $67,796 | 67.2% |
| 92134 | Imaging of retina | Office | 2023 | 428 | 1,401 | $139,846 | $38,428 | 27.5% |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | Office | 2023 | 208 | 215 | $121,475 | $35,447 | 29.2% |
| 92250 | Photography of the retina | Office | 2023 | 421 | 1,246 | $137,489 | $32,835 | 23.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 276 | 280 | $40,615 | $24,615 | 60.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 78 | 78 | $14,508 | $9,082 | 62.6% |
| 92285 | Photography of content of eyes | Office | 2023 | 367 | 546 | $41,496 | $8,178 | 19.7% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 23 | 68 | $10,000 | $6,063 | 60.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 65 | 72 | $18,360 | $2,327 | 12.7% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 18 | 19 | $3,705 | $1,687 | 45.5% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 38 | 57 | $1,710 | $581.05 | 34.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 116 | 1,582 | $3.2M | $1.1M | 35.5% |
| 67028 | Injection of drug into eye | Office | 2022 | 154 | 825 | $414,600 | $78,549 | 18.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 342 | 1,012 | $95,632 | $65,935 | 68.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 25 | 2,100 | $157,500 | $62,667 | 39.8% |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | Office | 2022 | 272 | 334 | $188,710 | $55,407 | 29.4% |
| 92134 | Imaging of retina | Office | 2022 | 421 | 1,337 | $133,270 | $37,672 | 28.3% |
| 92250 | Photography of the retina | Office | 2022 | 421 | 1,318 | $144,980 | $35,629 | 24.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 279 | 287 | $40,990 | $26,099 | 63.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 71 | 71 | $13,206 | $9,181 | 69.5% |
About Dr. John Frisbee, MD
Dr. John Frisbee, MD is a Ophthalmology healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437358868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Frisbee, MD has received a total of $12,347 in payments from pharmaceutical and medical device companies, with $529.62 received in 2024. These payments were reported across 171 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($8,380).
As a Medicare-enrolled provider, Frisbee has provided services to 10,503 Medicare beneficiaries, totaling 77,191 services with total Medicare billing of $6.3M. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Internal Medicine, Ophthalmology
- Location Metairie, LA
- Active Since 07/16/2007
- Last Updated 11/04/2016
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1437358868
Products in Payments
- OPMI Lumera (Device) $3,924
- OZURDEX (Drug) $3,003
- EYLEA (Biological) $1,866
- VABYSMO (Drug) $462.49
- Lucentis (Biological) $345.50
- Syfovre (Drug) $343.59
- Iluvien (Drug) $274.77
- TEPEZZA (Drug) $229.55
- EYLEA HD (Biological) $207.58
- Vabysmo (Drug) $196.50
- EVA Ophthalmic Surgical System (Device) $131.05
- EYLEA AFLIBERCEPT INJECTION (Biological) $129.92
- Constellation (Device) $124.83
- YUTIQ (Drug) $104.58
- Spectralis (Device) $89.98
- STELLARIS PC (Device) $82.99
- OCT OPHTHALMOSCOPE (Device) $66.36
- ILUVIEN (Drug) $46.02
- Izervay (Drug) $37.24
- ACTHAR (Biological) $22.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Metairie
Dr. Ethan Stern, Md, MD
Ophthalmology — Payments: $14,351
Ophthalmology $14,351
Gwen Cousins, Md, MD
Ophthalmology — Payments: $10,416
Ophthalmology $10,416
Benjamin Guidry, Md, MD
Ophthalmology — Payments: $9,044
Ophthalmology $9,044
Dr. Henry Haley, M.d, M.D
Ophthalmology — Payments: $8,019
Ophthalmology $8,019
Scott Lanoux, Md, MD
Ophthalmology — Payments: $7,607
Ophthalmology $7,607
Dr. Nicholas Frisard, M.d, M.D
Ophthalmology — Payments: $7,321
Ophthalmology $7,321